Novartis AG News Headlines

NVS 
$98.58
*  
0.35
0.35%
Get NVS Alerts
*Delayed - data as of Jan. 28, 2015 12:23 ET  -  Find a broker to begin trading NVS now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    NVS Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Is Mannkind the Next Takeover Target?
7/25/2010 4:55:00 AM - Seeking Alpha


Hedge Fund East Coast on Consensus vs. Variant Perception Investing
7/22/2010 2:30:00 AM - Seeking Alpha


Novartis On The Right Track (NVS, AZN, BMY, PFE, ACL, LLY, ABT)
7/19/2010 11:30:00 AM - Investopedia


Weekly Pharma Roundup: GSK Settles, Vivus Disappoints, Ely Lilly Axes
7/19/2010 4:17:00 AM - Seeking Alpha


Earnings Season Stats
7/15/2010 1:45:00 PM - Seeking Alpha


5 Stocks for Investing in Chinese Healthcare
7/15/2010 11:56:00 AM - Seeking Alpha


Drug Pipeline Pulse Check: High Expectations for Novartis
7/12/2010 2:25:00 PM - Seeking Alpha


Money Flows Into Biotech Startups
7/11/2010 4:33:00 AM - Seeking Alpha


The Failure of Capitalists to Act Like Capitalists
7/2/2010 4:05:00 AM - Seeking Alpha


The Market Is Wrong About Vanda
6/21/2010 2:19:00 AM - Seeking Alpha


Curis Tumbles on Failure of Cancer Drug Trial: Biotech's Latest Mishaps
6/20/2010 3:59:00 AM - Seeking Alpha


Novartis Close to New MS Drug
6/17/2010 8:33:00 AM - Seeking Alpha


Largest Foreign Companies by Market Cap
6/16/2010 1:18:00 PM - Seeking Alpha


Genzyme's MS Therapy on the Fast Track: Competition Heats Up
6/16/2010 5:33:00 AM - Seeking Alpha


Investors Are Shunning Biotech and Big Pharma Firms Despite Renewed Growth Prospects
6/15/2010 1:55:00 PM - Seeking Alpha


European Dividend ETFs Are More Attractive Than Bonds
6/15/2010 6:32:00 AM - Seeking Alpha


FDA Approval Positions Novartis in the Lead to Bring Oral MS Treatment to Market
6/13/2010 9:50:00 AM - Seeking Alpha


Novartis: Gilenia Clears Latest Regulatory Hurdle With Ease
6/11/2010 1:01:00 PM - Seeking Alpha


The World Cup Series: Emerging Markets of the Cup - Slovenia
6/9/2010 6:48:00 AM - Seeking Alpha


Equities Update: Late Surge Helps All but Tech
6/8/2010 4:30:00 PM - Seeking Alpha


Amgen's New Double-Play Drug (AMGN, MRK, GSK, LLY, NVS)
6/8/2010 1:01:00 PM - Investopedia


Amgen Likely to React Dramatically to Early FDA Approval of Osteoporosis Drug
6/2/2010 3:45:00 AM - Seeking Alpha


Just One Stock: This Food Giant Is a Recipe for Low-Risk Wealth Creation
6/1/2010 8:39:00 AM - Seeking Alpha


Impax Labs: Promising Pipeline and a Possible Takeover Target
5/13/2010 1:39:00 PM - Seeking Alpha


China's Outsourcing Future: Rising Costs Are Not Necessarily a Bad Thing
5/13/2010 11:12:00 AM - Seeking Alpha